CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

109 hedge funds and large institutions have $400M invested in CytomX Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 29 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-4
Holders Change %
-3.54%
% of All Funds
2.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
43
Reduced
29
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Nuveen Asset Management
Nuveen Asset Management
Illinois
$8.35M
2
BI
BVF Inc
California
$21M
3
Millennium Management
Millennium Management
New York
$5.33M
4
Victory Capital Management
Victory Capital Management
Texas
$22.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
$30M

Top Sellers

1
GPP
Great Point Partners
Connecticut
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$14.8M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
$0
4
State Street
State Street
Massachusetts
$19.4M
5
First Manhattan
First Manhattan
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DAM
126
Deltec Asset Management
New York
– -$129K -12,000 Closed
WG
127
Winton Group
United Kingdom
– -$113K -10,541 Closed
Walleye Trading
128
Walleye Trading
New York
– -$110K -10,200 Closed
Los Angeles Capital Management
129
Los Angeles Capital Management
California
– -$108K -10,057 Closed
Simplex Trading
130
Simplex Trading
Illinois
– -$1K -144 Closed
AG
131
Advisor Group
Arizona
– -$1K -100 Closed
2 3 4 5
6